[HTML][HTML] Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
HJ Yeom, HH Kim, HJ Kim, S Park, JY Jang… - … and Risk Management, 2021 - e-jperm.org
Objective: The labeling status of culprit drugs of Severe Cutaneous Adverse Reactions
(SCAR) was evaluated by comparing the labeling status of the US Food and Drug …
(SCAR) was evaluated by comparing the labeling status of the US Food and Drug …